These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
999 related items for PubMed ID: 16085017
21. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Salehi A, Ocampo M, Verhaagen J, Swaab DF. Exp Neurol; 2000 Jan; 161(1):245-58. PubMed ID: 10683291 [Abstract] [Full Text] [Related]
22. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Ikonomovic MD, Nocera R, Mizukami K, Armstrong DM. Exp Neurol; 2000 Dec; 166(2):363-75. PubMed ID: 11085901 [Abstract] [Full Text] [Related]
23. trk-immunoreactivity in the monkey central nervous system: forebrain. Kordower JH, Chen EY, Sladek JR, Mufson EJ. J Comp Neurol; 1994 Nov 01; 349(1):20-35. PubMed ID: 7852624 [Abstract] [Full Text] [Related]
24. Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging. Madhusudan A, Sidler C, Knuesel I. Eur J Neurosci; 2009 Sep 01; 30(6):1064-76. PubMed ID: 19735296 [Abstract] [Full Text] [Related]
25. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: a comparison between the gray mouse lemur (Microcebus murinus, primates) and rat. Harkany T, Dobszay MB, Cayetanot F, Härtig W, Siegemund T, Aujard F, Mackie K. Neuroscience; 2005 Sep 01; 135(2):595-609. PubMed ID: 16129564 [Abstract] [Full Text] [Related]
26. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Neurobiol Dis; 2005 Nov 01; 20(2):574-82. PubMed ID: 15916898 [Abstract] [Full Text] [Related]
28. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I, Blanco R, Carmona M, Puig B. J Neural Transm (Vienna); 2001 Nov 01; 108(12):1397-415. PubMed ID: 11810404 [Abstract] [Full Text] [Related]
29. Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease. Mufson EJ, Kordower JH. Prog Clin Biol Res; 1989 Nov 01; 317():401-14. PubMed ID: 2557638 [Abstract] [Full Text] [Related]
30. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease. Woodhouse A, Vickers JC, Dickson TC. Acta Neuropathol; 2006 Oct 01; 112(4):429-37. PubMed ID: 16855832 [Abstract] [Full Text] [Related]
31. GABAergic basal forebrain neurons that express receptor for neurokinin B and send axons to the cerebral cortex. Furuta T, Koyano K, Tomioka R, Yanagawa Y, Kaneko T. J Comp Neurol; 2004 May 17; 473(1):43-58. PubMed ID: 15067717 [Abstract] [Full Text] [Related]
32. Molecular forms of acetylcholinesterases in Alzheimer's disease. Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH. Fed Proc; 1986 Dec 17; 45(13):2982-8. PubMed ID: 2430839 [Abstract] [Full Text] [Related]
33. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. Emre M, Heckers S, Mash DC, Geula C, Mesulam MM. J Comp Neurol; 1993 Oct 01; 336(1):117-34. PubMed ID: 8254109 [Abstract] [Full Text] [Related]
34. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease. Szigeti C, Bencsik N, Simonka AJ, Legradi A, Kasa P, Gulya K. Brain Res Bull; 2013 May 01; 94():9-16. PubMed ID: 23357177 [Abstract] [Full Text] [Related]
35. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. Chan-Palay V. J Comp Neurol; 1988 Jul 22; 273(4):543-57. PubMed ID: 2463283 [Abstract] [Full Text] [Related]
36. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Tomimoto H, Ohtani R, Shibata M, Nakamura N, Ihara M. Dement Geriatr Cogn Disord; 2005 Jul 22; 19(5-6):282-8. PubMed ID: 15785029 [Abstract] [Full Text] [Related]
37. Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease. Ahmadian SS, Rezvanian A, Peterson M, Weintraub S, Bigio EH, Mesulam MM, Geula C. Neurobiol Aging; 2015 Dec 22; 36(12):3163-3170. PubMed ID: 26417681 [Abstract] [Full Text] [Related]
38. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Gibbs RB. Brain Res; 1996 May 13; 720(1-2):61-8. PubMed ID: 8782897 [Abstract] [Full Text] [Related]
39. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Exp Neurol; 1997 Jul 13; 146(1):91-103. PubMed ID: 9225742 [Abstract] [Full Text] [Related]
40. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L, Hamel E. Neuroscience; 2005 Jul 13; 132(1):73-86. PubMed ID: 15780468 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]